Privia Health Group, Inc. Payments of Stock Issuance Costs
Privia Health Group, Inc. (PRVA) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2024-02-27
- Privia Health Group, Inc. payments of stock issuance costs for the quarter ending 2022-12-31 was $0.00.
- Privia Health Group, Inc. payments of stock issuance costs for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Privia Health Group, Inc. payments of stock issuance costs for the quarter ending 2021-12-31 was $0.00.
- Privia Health Group, Inc. payments of stock issuance costs for the quarter ending 2021-09-30 was $33.00K.
- Privia Health Group, Inc. payments of stock issuance costs for fiscal 2023 was $0.00.
- Privia Health Group, Inc. payments of stock issuance costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Privia Health Group, Inc. payments of stock issuance costs for fiscal 2021 was $12.69M.
- Privia Health Group, Inc. payments of stock issuance costs for fiscal 2020 was $0.00.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-27 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $33.00K derived: sum of 2 quarters · filed 2024-02-27 | $12.69M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $12.69M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $12.66M 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $0.00 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-09 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |